- Mithra secures court protection measures to advance monetization process
- Mithra reports full year 2023 financial results
- Mithra announces changes to its executive management
- Mithra initiates monetization process, receives bridge loan from existing lenders
- DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
- Mithra sells shares in Mayne Pharma
- Mithra updates on cash position
- Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
- Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
- Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial
More ▼
Key statistics
On Friday, Mithra Pharmaceuticals SA (MITRA:BRU) closed at 0.216, 7.46% above its 52-week low of 0.201, set on Mar 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.22 |
---|---|
High | 0.2245 |
Low | 0.2155 |
Bid | 0.214 |
Offer | 0.224 |
Previous close | 0.22 |
Average volume | 74.08k |
---|---|
Shares outstanding | 66.91m |
Free float | 54.24m |
P/E (TTM) | -- |
Market cap | 14.72m EUR |
EPS (TTM) | -2.51 EUR |
Data delayed at least 15 minutes, as of Apr 26 2024 16:35 BST.
More ▼